Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTotally Regulatory News (TLY)

Share Price Information for Totally (TLY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6.25
Bid: 6.00
Ask: 6.50
Change: 1.35 (25.71%)
Spread: 0.50 (8.333%)
Open: 5.50
High: 6.60
Low: 6.60
Prev. Close: 5.25
TLY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year results for six months end 30 June 2016

28 Sep 2016 07:00

RNS Number : 0104L
Totally PLC
28 September 2016
 

Dissemination of a Regulatory Announcement that contains inside information according to REGULATION (EU) No 596/2014 (MAR).

 

 

28 September 2016

Totally PLC

("Totally", "the Company" or "the Group")

 

Half-year results for the six months ended 30 June 2016

 

Totally (AIM: TLY), the provider of a range of services to the healthcare sector, is pleased to announce its interim results for the six months ended 30 June 2016 ("H1 2016").

 

Highlights

· Significant progress made delivering a progressive 'buy and build' strategy, aimed at establishing Totally as a leading provider of 'out of hospital' care in the UK

· Two acquisitions completed and successfully integrated during H1 2016:

o Premier Physical Healthcare Limited ("Premier"), a provider of physical healthcare services to both public and private patients, for up to £6.75 million and subscription to raise £6.2 million completed in April 2016

o About Health Limited ("About Health"), a provider of community based health services under contract to the NHS with a focus on dermatology services, for up to £7.7 million - completed June 2016

· Following the acquisitions, Totally has four subsidiaries (Totally Health, My Clinical Coach, Premier and About Health) providing a range of preventative and responsive healthcare services in community settings, GP surgeries and patients' homes, from pre-diagnosis through to discharge

· Premier performing strongly since acquisition in April 2016:

o Prison contracts covering 21 locations around the UK secured in April 2016 with a total value of £300,000 per annum

o Three contract wins secured for physiotherapy services, together accounting for revenues of £120,000 per annum

o Awarded ''Best Physiotherapy Chain 2016 - UK'' in the 2016 International Life Science Awards

· My Clinical Coach, the direct to consumer health coaching service, was launched at the end of June 2016

· Totally Health, supporting patients with long-term health conditions, entered into a three year partnership agreement with Healthwise in April 2016 to support B2B and B2C services

· Totally continues to evaluate value accretive acquisition opportunities focused on the UK NHS outsourced healthcare services market, estimated to be worth in the region of £20 billion per year

 

Financial Overview

· Group turnover £936,000 (H1 2015: £418,000)

· Gross profit £286,000 (H1 2015: £327,000)

· EBITDA loss excluding acquisition costs £406,000 (H1 2015: EBITDA loss £69,000)

· EBITDA loss including acquisition costs £844,000 (H1 2015: EBITDA loss £69,000)

 

 

Chairman's Statement

 

I am pleased to report a successful half year during which we completed two planned acquisitions in line with our progressive buy and build strategy. We continue to deliver on our vision of becoming the leading provider of 'out of hospital' care in the UK. In addition to this, we also launched the My Clinical Coach service, whereby our team of trained clinicians provides clinical coaching direct to consumers on a fee-based service. The service is the first of its kind to be launched in the UK.

 

I was appointed to the Board in September 2015, with the express intention of building a broadly-based Group specialising in 'out of hospital' services. The acquisition of Premier, a physiotherapy and musculoskeletal service provider, in April 2016 was the first acquisition subsequent to my appointment and was followed by the acquisition of a leading dermatology services provider, About Health, in June 2016. These acquisitions only form part of the results for the Group in the period, but represent a significant start to building the future strategy and growth of this Company. I am delighted to say that the acquired businesses are performing excellently.

 

The six months' results showed turnover of £936,000 (2015: £418,000) and a loss of £844,000 (2015: £69,000). The loss for the period included £438,000 of acquisition related costs.

 

I am delighted with our progress to date and look forward to bringing you news of further acquisitions as we continue to expand our 'out of hospital' offering in the future.

 

It would be remiss of me not to thank all stakeholders for their support in looking to build a profitable platform for future growth.

 

Bob Holt

Chairman

28 September 2016

 

 

Operational Review

 

I can only echo the comments made above by our Chairman, Bob Holt. The first half of 2016 was a transformational period for Totally, and this progress continues across the Group. The first two acquisitions are already proving to be very successful and are adding to the Group's range of out of hospital services, along with the expertise of the people within those companies. The integration of the new businesses into the Group has already opened up new business opportunities, and as we continue to grow I am confident that we will deliver our stated aim to become one of the UK's leading providers of 'out of hospital' services.

 

Both Premier Physical Healthcare and About Health have seen successes since joining the Group, with new contract wins and the securing of contract renewals.

 

Totally Health successfully launched its new business-to-consumer (B2C) service - My Clinical Coach and also continued to deliver its Clinical Health Coaching services on a business-to-business (B2B) basis.

 

As well as thanking all of our shareholders for their continued support, I would also like to thank everyone who is part of 'Team Totally' as it is their commitment and approach that enables us to deliver the high quality services to patients and customers across the Group.

 

 

Wendy Lawrence

Chief Executive Officer

28 September 2016

 

 

 

Financial Review

 

The Group's half yearly financial results include the financial performance of Totally plc and Totally Health for the full half year, the three months from April to June 2016 for Premier Physical Healthcare Limited and half of June 2016 for About Health Limited.

 

During the first half of 2016, the Group continued to invest in IT and recruit suitable staff to build the infrastructure to best position the Group to execute its buy and build strategy. This investment will help to identify and streamline business processes, in terms of the bid process, administration and collaboration across the Group's companies. It is envisaged that this will result in cost savings through economies of scale and a move to a shared service model, where appropriate.

 

In addition to cost savings, the Group companies will also be able to collaborate on larger and more integrated bids. The collaboration and infrastructure investment should afford for increasingly competitive bid offerings. These bids will be underpinned by efficient delivery of services, while maintaining quality and profit margin.

 

Although the service's full launch took place in August 2016, the Group's investment in My Clinical Coach is expected to generate more material revenues from the last quarter of 2016 onwards.

 

Details of the revenue contribution of the subsidiaries are included in the segmental reporting section of the financial information.

 

Donald Baladasan

Chief Financial Officer

28 September 2016

 

 

For further information please contact:

Totally plc

020 3866 3335

Wendy Lawrence, Chief Executive

Bob Holt, Chairman

Allenby Capital Limited (Nominated Adviser & Broker)

020 3328 5656

Nick Athanas

Nick Naylor

Alex Brearley

 

Yellow Jersey PR

Felicity Winkles

0203 735 8828

Joe Burgess

0203 735 8918

Josh Cole

0203 735 8824

 

 

 

 

Interim Consolidated Income Statement

For the six months ended 30 June 2016

 

Six months ended 30 June 2016

Six months ended 30 June 2015

Year ended 31 December 2015

(Unaudited)

(Unaudited)

(Audited)

£000

£000

£000

Revenue

936

418

577

Cost of sales

(650)

(91)

(184)

Gross profit

286

327

393

Administrative expenses

(689)

(396)

(752)

Exceptional items

(438)

-

-

Loss before interest, tax and depreciation

(841)

(69)

(359)

Depreciation

(3)

(2)

(4)

Operating loss

(844)

(71)

(363)

Share issue costs

-

-

(49)

Finance costs

-

(1)

(1)

Loss before taxation

(844)

(72)

(413)

Income tax

-

-

-

Loss from continuing operations

(844)

(72)

(413)

Loss attributable to the equity shareholders of the parent company

(844)

(72)

(413)

 

 

 

 

 

 

 

Earnings per share (Note 2)

 

 

Basic and diluted: Pence

 

 

Continuing operations

(5)

(2)

(15)

Loss per share

(5)

(2)

(15)

 

 

The accompanying notes form part of the unaudited interim report.

 

Interim Consolidated Statement of Changes in Equity

For the six months ended 30 June 2016

 

Share capital

Share premium account

Profit and loss account

Equity shareholders' deficit

£000

£000

£000

£000

 

At 1 January 2015 (Audited)

2,453

4,147

(6,739)

(139)

Comprehensive loss for the period (Unaudited)

Issue of share capital (Unaudited)

Credit on issue of warrants (Unaudited)

 

-

1

-

-

1

-

(72)

-

13

 

(72)

2

13

 

At 30 June 2015 (Unaudited)

2,454

4,148

(6,798)

(196)

 

At 1 January 2015 (Audited)

2,453

4,147

(6,739)

(139)

Comprehensive loss for the year (Audited)

-

-

(413)

(413)

Issue of share capital (Audited)

Credit on issue of warrants (Audited)

 

602

-

387

-

-

55

989

55

At 31 December 2015 (Audited)

3,055

4,534

(7,097)

492

 

At 1 January 2016 (Audited)

3,055

4,534

(7,097)

492

Comprehensive loss for the year (Unaudited)

-

-

(844)

(844)

Issue of share capital (Unaudited)

Credit on issue of warrants (Unaudited)

 

1,000

-

5,110

-

-

14

6,110

14

At 30 June 2016 (Unaudited)

4,055

9,644

(7,927)

5,772

 

 

 

 

The accompanying notes form part of the unaudited interim report

 

 

Interim Consolidated Statement of Financial Position

As at 30 June 2016

 

30 June 2016

30 June 2015

31 December 2015

(Unaudited)

(Unaudited)

(Audited)

£000

£000

£000

Non-Current Assets

Intangible fixed assets

12,898

-

218

Fixed assets

25

5

6

12,923

5

224

Current Assets

Trade and other receivables

1,115

194

78

Cash and cash equivalent

2,947

73

359

4,062

267

437

Total Assets

16,985

272

661

Current Liabilities

Trade and other payables

(827)

(468)

(169)

Borrowings

(80)

-

-

Deferred acquisition consideration

(2,804)

-

-

(3,711)

(468)

(169)

Net Current Assets/ (Liabilities)

351

(201)

268

Long Term Liabilities

Deferred acquisition consideration

(7,477)

-

-

Amounts falling due after more than one year

(25)

-

-

(7,502)

-

-

Net Assets/ (Liabilities)

5,772

(196)

492

Shareholders' Equity

Share capital

4,055

2,454

3,055

Share premium account

9,644

4,148

4,534

Retained earnings

(7,927)

(6,798)

(7,097)

Equity shareholders' funds/ (deficit)

5,772

(196)

492

 

The accompanying notes form part of the unaudited interim report

 

 

 

 

Interim Consolidated Cash Flow Statement

For the six months ended 30 June 2016

 

Six months ended 30 June 2016

Six months ended 30 June 2015

Year ended 31 December 2015

(Unaudited)

(Unaudited)

(Audited)

£000

£000

£000

Cash flow from operating activities:

Loss for the period

(844)

(72)

(413)

Adjustments for:

Amortization and depreciation

Options and warrants charge

3

14

2

13

4

55

Movements in working capital:

Movement in trade and other receivables

(179)

(42)

74

Movement in trade and other payables

158

(19)

(318)

Net cash flows from operating activities

(848)

(118)

(598)

Cash flow from investing activities:

Purchases of property, plant and equipment

(10)

(1)

(4)

Development of intangible assets

(322)

-

(218)

Acquisition of subsidiaries, net of cash acquired

(2,342)

-

-

Net cash flows from investing activities

(2,674)

(1)

(222)

Cash outflow before financing

(3,522)

(119)

(820)

Cash flow from financing activities:

Issue of share capital, net

6,110

2

989

Net cash flow from financing activities

6,110

2

989

Net increase/(decrease) in cash and cash equivalents

2,588

(117)

169

Cash and cash equivalents at beginning of the period

359

190

190

Cash and cash equivalents at end of the period

2,947

73

359

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The accompanying notes form part of the unaudited interim report.

Notes to the Interim Results

 

1. Basis of preparation

 

Totally plc is a public limited company incorporated in the United Kingdom under the Companies Act 2006 (registration number: 3870101). The Company's ordinary shares are admitted to trading on the AlM Market of the London Stock Exchange ("AIM").

 

The Group's principal activities in the period under review have been the provision of innovative solutions to the healthcare sector, which are provided by the Group's wholly owned subsidiaries, Totally Health Limited, Premier Physical Healthcare Limited and About Health Limited.

 

The interim report and accounts for the six months ended 30 June 2016 have been prepared using the recognition and measurement principles of International Financial Reporting Standards and Interpretations as endorsed by the European Union (collectively "Adopted IFRS").

 

These condensed consolidated interim financial statements for the half-year ended 30 June 2016 have been prepared in accordance with the AIM Rules for Companies and should be read in conjunction with the annual financial statements for the year ended 31 December 2015, which have been prepared in accordance with IFRS as adopted by the European Union. The interim consolidated financial statements do not include all the information and disclosures required in the annual financial statements.

 

The interim report and accounts have been prepared on the basis of the accounting policies set out in the Group's 2015 Annual Report and Accounts and on the basis of the principal accounting policies that the Group expects to apply in its financial statements for the year ending 31 December 2016.

 

The interim report and accounts do not comprise statutory accounts within the meaning of section 434 of the Companies Act 2006. These condensed consolidated interim financial statements were approved by the Board of Directors on 27 September 2016. The results for the six months to 30 June 2016 and the comparative results for six months to 30 June 2015 are unaudited. The comparative figures for the year ended 31 December 2015 do not constitute the statutory financial statements for that year.

 

As at 30 June 2016 net current assets were £0.35m made up of cash balances of £2.95m, trade and other receivables of £1.12m with current liabilities of £3.71m (as at 30 June 2016). The current liabilities include deferred contingent consideration of £2.8m for acquisitions made in the period.

 

Cash expected to be generated within the Group over the next year is expected to contribute to covering future liabilities. The Directors believe that a combination of the Group's current cash, projected revenues from existing and future contracts and continued shareholder support will enable the Group to meet its obligations and to implement its business plan in full. Inherently, there can be no certainty in these matters, but the Directors believe that the Group's internal trading forecasts are realistic and that the going concern basis of preparation continues to be appropriate.

  

 

2. Earnings per share

 

Basic loss per share is calculated by dividing the loss attributable to equity holders of the Company by the weighted average number of ordinary shares in issue during the period.

None of the share options or warrants in issue had a dilutive effect on earnings per share.

 

Six months ended 30 June 2016

Six months ended 30 June 2015

Year ended 31 December 2015

(Unaudited)

(Unaudited)

(Audited)

Loss (continuing operations) (£000)

(844)

(72)

(413)

Weighted average number of shares used

in basic and diluted earnings ('000)

15,860

3,980

2,828

Basic and diluted earnings per share (continuing operations) (Pence)

(5)

(2)

(15)

 

The loss per share for the six months ended 30 June 2015 has been restated to reflect a share consolidation that occurred in September 2015. The Company reorganized its share capital and every 100 existing ordinary shares of 0.1 pence were consolidated into 1 new ordinary share of 10 pence.

 

4. Segmental analysis

 

The segment information is presented in respect of the Group's operating segments. Segments are determined by reference to the internal reports reviewed by the Board.

The chief operating decision maker (''CODM'') regularly reviews the revenue streams of the Group.

During the reporting period, the Company acquired two business, Premier Physical Healthcare Limited and About Health Limited, and therefore for the purpose of assessment of performance, the reportable operating segments have been reviewed on the basis of the changes to the organization's structure.

 

As at 30 June 2016, the Group reports its segmental information on the basis of its existing businesses at 31 December 2015 and its acquired businesses from 1 January 2016.

Existing business segment represents the innovative solutions to the healthcare sector provided by Totally Health Limited and head office costs.

Acquired business segment represents the following:

Premier Physical Healthcare Limited is a provider of physical healthcare services to both public and private patients.

About Health Limited is a provider of dermatology services to the NHS.

 

  

 

 

A breakdown of revenue and operating (loss)/profit are as follows:

 

 

 

 

 

 

Six months ended 30 June 2016

Six months ended 30 June 2015

Year ended 31 December 2015

(Unaudited)

(Unaudited)

(Audited)

Revenue

Existing business segment (£000)

141

418

577

Acquired business segment (£000)

795

-

-

936

418

577

 

Operating loss from existing business

Existing business segment (£000)

(479)

(71)

(363)

Administrative expenses exceptional items *

(438)

-

-

Share issue costs

-

-

(49)

Finance costs

-

(1)

(1)

Loss before tax

(917)

(72)

(413)

Operating profit from acquired business

Acquired business segment (£000)

73

-

-

Profit before tax

73

-

-

 

\* The exceptional charge of £438,420 is expenditure associated with the costs of acquisitions.

 

4. Dividends

 

No dividend is proposed for the six months ended 30 June 2016.

5. Events after the reporting period

 

On 24 August 2016, The High Court order cancelling the balance standing to the credit of the Company's share premium account was registered at Companies House. This was following approval by shareholders and the approval of the High Court.

As a consequence, a balance of £9.61 million standing to the credit of the Company's share premium account has been cancelled, thereby creating distributable reserves. This process had no effect on the overall net asset position of the Company.

6. Distribution of Interim Report

 

A copy of the interim report will be available shortly on the Company's website (www.totallyplc.com) in accordance with Rule 26 of the AIM Rules for Companies and copies will also be available from the Company's registered office located at Hamilton House, Mabledon Place, London WC1H 9BB.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR LRMMTMBATTMF
Date   Source Headline
7th May 20247:00 amRNSTrading Update
19th Apr 20245:15 pmRNSHolding(s) in Company
19th Apr 20243:00 pmRNSHolding(s) in Company
11th Mar 20247:00 amRNSContract win
7th Mar 20246:00 pmRNSHolding(s) in Company
5th Feb 20247:00 amRNSDirector/PDMR Shareholding
1st Feb 20243:00 pmRNSDirectorate Change
10th Jan 20247:00 amRNSContract Extension
8th Dec 20233:30 pmRNSHolding(s) in Company
6th Dec 20237:00 amRNSDirector/PDMR Shareholding
4th Dec 20235:45 pmRNSHolding(s) in Company
1st Dec 20239:33 amRNSDirector/PDMR Shareholding
1st Dec 20237:00 amRNSDirector/PDMR Shareholding
30th Nov 20237:00 amRNSDirector/PDMR Shareholding
28th Nov 20237:00 amRNSAdviser Update
28th Nov 20237:00 amRNSDirectorate Change
28th Nov 20237:00 amRNSInterim Results
22nd Nov 20237:00 amRNSNotice of Interim Results & Investor Presentation
4th Oct 20234:15 pmRNSHolding(s) in Company
11th Sep 202312:00 pmRNSExercise of options and change to TVR
1st Sep 202312:25 pmRNSResult of AGM
1st Sep 20237:00 amRNSAGM Statement
25th Jul 20237:00 amRNSHolding(s) in Company
18th Jul 20234:00 pmRNSExercise of options and change to TVR
13th Jul 20233:30 pmRNSHolding(s) in Company
12th Jul 202312:15 pmRNSHolding(s) in Company
12th Jul 20237:00 amRNSDividend Timetable and EPS - Corrections
11th Jul 20237:00 amRNSHolding(s) in Company
10th Jul 20237:00 amRNSPreliminary results
6th Jul 20237:00 amRNSNotice of Preliminary Results
5th Jul 20231:00 pmRNSExercise of options and change to TVR
22nd May 20237:00 amRNSTotally secures multiple contract extensions
16th May 202312:30 pmRNSExercise of options & change to TVR
2nd May 20237:01 amRNSTrading Update for 12 months ending 31 March 2023
2nd May 20237:00 amRNSAppointment of Nomad and Joint Corporate Broker
26th Apr 20237:00 amRNSFurther new contract win for urology services
18th Apr 20237:00 amRNSTotally to help reduce waiting lists in Wales
12th Apr 20237:00 amRNSTotally wins new contract for urology services
4th Apr 20237:00 amRNSTotally first to fully mobilise on NHS SVCC model
31st Mar 20235:00 pmRNSTotal Voting Rights
31st Mar 20237:00 amRNSDirector/PDMR Shareholding
20th Mar 20231:42 pmRNSExercise of options, PDMR shareholding & TVR
16th Mar 20231:34 pmRNSDirector/PDMR Shareholding
10th Mar 20231:49 pmRNSHolding(s) in Company
10th Mar 20237:00 amRNSHolding(s) in Company
8th Mar 20232:09 pmRNSDirector/PDMR Shareholding
2nd Mar 20239:05 amRNSSecond Price Monitoring Extn
2nd Mar 20239:00 amRNSPrice Monitoring Extension
2nd Mar 20237:00 amRNSTrading Update
28th Feb 20235:00 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.